La tarification au prix de référence: quel impact sur le marché pharmaceutique ?

Elise Verpillot

Revue d'économie politique, 2009, vol. 119, issue 5, 795-816

Abstract: Increases in national pharmaceutical spending have led governments to adopt new measures aimed at promoting price competition. One such approach to regulate the pharmaceutical market is reference pricing. A reference price system categorises products into groups so that the reference price is the maximum reimbursement of the third party payer for all products in that group. Using a vertical product differentiation model, we deduce that the reference price system can generate a drug price cut. However the impact on public expenditures is uncertain.

Date: 2009
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://www.cairn.info/load_pdf.php?ID_ARTICLE=REDP_195_0795 (application/pdf)
http://www.cairn.info/revue-d-economie-politique-2009-5-page-795.htm (text/html)
free

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cai:repdal:redp_195_0795

Access Statistics for this article

More articles in Revue d'économie politique from Dalloz
Bibliographic data for series maintained by Jean-Baptiste de Vathaire ().